---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-25-000007"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T00:48:28.027899+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics guides 2025 revenue $735-745M, adj. EBITDA $55-58M; issues retention bonuses

## Summary
- 2025 revenue guidance $735-745M (midpoint $740M) vs FY24 $661M, ~12% YoY growth.
- 2025 adjusted EBITDA guidance $55-58M vs FY24 $38.5M, up 43-51%.
- Long-range plan: 12-13% annual revenue growth; NGS growth ~25% per year.
- Retention bonuses: CFO Sherman ($400K cash + $750K RSUs), Presidents Harris and Stone each similar with vesting thru 2026.
- Expects to retire 2025 convertible notes due May 1 with cash on hand.

## SEC filing metadata
- accession: 0001077183-25-000007
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/0001077183-25-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000007/neo-20250114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-25-000007
- JSON: https://secwatch.observer/filing/0001077183-25-000007.json
- Plain text: https://secwatch.observer/filing/0001077183-25-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.